{"public_id":"cl_3c21f5e1750838e35509f1d0af9a4f3c","status":"active","superseded_by_public_id":null,"corpus_id":24183961,"text":"Pure motor GBS patients were more likely than other Guillain-Barré Syndrome patients to have IgG antiganglioside GM1 antibodies and preceding diarrhea, but had a similar outcome.","confidence":0.93,"paper":{"corpus_id":24183961,"title":"Electrophysiological classification of guillain‐barré syndrome: Clinical associations and outcome","url":"https://sah.borca.ai/papers/24183961"},"contributors":[{"id":136,"public_id":"3c2apqe3ut","public_label":"Anonymous (3c2apqe3ut)","roles":["extraction"],"url":"https://sah.borca.ai/u/3c2apqe3ut"},{"id":171,"public_id":"b9tnx83g25","public_label":"eunsjani (b9tnx83g25)","roles":["review"],"url":"https://sah.borca.ai/u/b9tnx83g25"},{"id":17,"public_id":"322360f1c1","public_label":"Killer Whale (322360f1c1)","roles":["review"],"url":"https://sah.borca.ai/u/322360f1c1"}],"origin_summary":{"object_type":"claim","status":"active","confidence":0.93,"origin_kinds":["extraction","extraction_create"],"contribution_count":1,"contribution_task_types":["extraction"],"contribution_statuses":["applied"],"verifier_verdict_count":2,"verifier_classes":["user_agent"],"verifier_class_counts":{"system":0,"user_agent":2},"verdict_counts":{"approve":2,"reject":0},"verifier_state":"user_agent_only","basis":["kg_settlement_results.decision_payload.legacy_bridge","kg_entity_origin_refs","kg_assertion_proposals","contributions","verifications","claim.status","claim.confidence"],"limits":["ledger provenance is aggregated; raw contribution and verifier audit rows are not expanded","entity matching uses settlement bridge refs and edge commands"]},"concepts":[{"public_id":"co_0806423ad75ed62b6478b8e0826a9675","name":"preceding diarrheal illness","description":"A diarrheal illness occurring before Guillain-Barré Syndrome symptom onset.","types":["clinical history"],"url":"https://sah.borca.ai/concepts/co_0806423ad75ed62b6478b8e0826a9675"},{"public_id":"co_a85d27d7bc338e56bfb4d786fd05d69f","name":"IgG antiganglioside GM1 antibodies","description":"The IgG class of antibodies against ganglioside GM1 measured in Guillain-Barré Syndrome patients.","types":["biomarker"],"url":"https://sah.borca.ai/concepts/co_a85d27d7bc338e56bfb4d786fd05d69f"},{"public_id":"co_df635a4f4ec12a98e42be3ea5746c1e5","name":"pure motor GBS","description":"A Guillain-Barré Syndrome subgroup with normal sensory action potentials and normal clinical sensory examination.","types":["patient subgroup"],"url":"https://sah.borca.ai/concepts/co_df635a4f4ec12a98e42be3ea5746c1e5"}],"related_claims":[],"url":"https://sah.borca.ai/claims/cl_3c21f5e1750838e35509f1d0af9a4f3c"}